rs201331677
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_003052.5(SLC34A1):c.1724C>T(p.Thr575Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000422 in 1,612,388 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_003052.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC34A1 | NM_003052.5 | c.1724C>T | p.Thr575Ile | missense_variant | Exon 13 of 13 | ENST00000324417.6 | NP_003043.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152220Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000319 AC: 8AN: 250534Hom.: 0 AF XY: 0.0000443 AC XY: 6AN XY: 135362
GnomAD4 exome AF: 0.0000438 AC: 64AN: 1460168Hom.: 0 Cov.: 32 AF XY: 0.0000427 AC XY: 31AN XY: 726082
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152220Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74374
ClinVar
Submissions by phenotype
not provided Uncertain:2
- -
This sequence change replaces threonine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 575 of the SLC34A1 protein (p.Thr575Ile). This variant is present in population databases (rs201331677, gnomAD 0.007%). This missense change has been observed in individuals with SLC34A1-related conditions (PMID: 28893421; internal data). ClinVar contains an entry for this variant (Variation ID: 548679). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt SLC34A1 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Hypophosphatemic nephrolithiasis/osteoporosis 1;C3150652:Fanconi renotubular syndrome 2;C4310473:Hypercalcemia, infantile, 2 Pathogenic:1
- -
Nephrocalcinosis;C0392525:Nephrolithiasis Pathogenic:1
- -
SLC34A1-related disorder Uncertain:1
The SLC34A1 c.1724C>T variant is predicted to result in the amino acid substitution p.Thr575Ile. This variant was reported in the homozygous state in an individual with nephrocalcinosis and hypercalcemia (Daga et al 2018. PubMed ID: 28893421). It was also reported in the heterozygous state in two additional patients from a large exome sequencing cohort; however, clinical information was not provided (Supp. Table 1 in Capalbo A et al 2019. PubMed ID: 31589614). This variant is reported in 0.0070% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/5-176825091-C-T). Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at